UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.321-326

2012

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

Clinical pharmacology and therapeutics, 2015-08, Vol.98 (2), p.127-134

2015

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

Clinical pharmacology and therapeutics, 2014-04, Vol.95 (4), p.376-382

2014

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Clinical pharmacology and therapeutics, 2013-05, Vol.93 (5), p.402-408

2013

Volltextzugriff (PDF)

Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.175-181

2014

Volltextzugriff (PDF)

Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System

Clinical pharmacology and therapeutics, 2014-09, Vol.96 (3), p.307-309

2014

Volltextzugriff (PDF)

High‐Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic‐Driven Medicine

Clinical and translational science, 2017-03, Vol.10 (2), p.67-77

2017

Volltextzugriff (PDF)

Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver

Clinical pharmacology and therapeutics, 2015-08, Vol.98 (2), p.205-215

2015

Volltextzugriff (PDF)

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial

Clinical pharmacology and therapeutics, 2016-07, Vol.100 (1), p.63-66

2016

Volltextzugriff (PDF)

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study

Breast cancer research and treatment, 2017-11, Vol.166 (1), p.277-287

2017

Volltextzugriff (PDF)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting

Clinical and translational science, 2017-05, Vol.10 (3), p.143-146

2017

Volltextzugriff (PDF)

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects

British journal of cancer, 2013-10, Vol.109 (9), p.2331-2339

2013

Volltextzugriff (PDF)

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

The pharmacogenomics journal, 2009-08, Vol.9 (4), p.258-264

2009

Volltextzugriff (PDF)

Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation

Annals of oncology, 2013-07, Vol.24 (7), p.1867-1873

2013

Volltextzugriff (PDF)

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.37-44

2017

Volltextzugriff (PDF)

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy

British journal of cancer, 2010-01, Vol.102 (2), p.294-300

2010

Volltextzugriff (PDF)

A SNP in Steroid Receptor Coactivator-1 Disrupts a GSK3β Phosphorylation Site and Is Associated with Altered Tamoxifen Response in Bone

Molecular endocrinology (Baltimore, Md.), 2012-02, Vol.26 (2), p.220-227

2012

Volltextzugriff (PDF)

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.37-44

2017

Volltextzugriff (PDF)

Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group

Cancer chemotherapy and pharmacology, 2011-10, Vol.68 (4), p.863-870

2011

Volltextzugriff (PDF)

MCF7/LCC9 : An antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen

Cancer research (Chicago, Ill.), 1997-08, Vol.57 (16), p.3486-3493

1997

Volltextzugriff (PDF)

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer

The pharmacogenomics journal, 2017-12, Vol.17 (6), p.521-527

2017

Volltextzugriff (PDF)

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling

Oncogene, 2003-10, Vol.22 (47), p.7316-7339

2003

Volltextzugriff (PDF)

Cellular and molecular pharmacology of antiestrogen action and resistance

Pharmacological reviews, 2001-03, Vol.53 (1), p.25

2001

Volltextzugriff (PDF)

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells

The Journal of steroid biochemistry and molecular biology, 1998-12, Vol.67 (5), p.391-402

1998

Volltextzugriff (PDF)

Estrogen Receptor Genotypes, Menopausal Status, and the Effects of Tamoxifen on Lipid Levels: Revised and Updated Results

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.626-629

2010

Volltextzugriff (PDF)

1 – 25 von 443

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(395)
Mit Volltextzugriff
(379)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(443)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate

Prerequisites to Implementing a Pharmacogenomics Program in a Large Health-Care System

High‐Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic‐Driven Medicine

Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver

Implementation of a pharmacogenomics consult service to support the INGENIOUS trial

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy

A SNP in Steroid Receptor Coactivator-1 Disrupts a GSK3β Phosphorylation Site and Is Associated with Altered Tamoxifen Response in Bone

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group

MCF7/LCC9 : An antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling

Cellular and molecular pharmacology of antiestrogen action and resistance

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells

Estrogen Receptor Genotypes, Menopausal Status, and the Effects of Tamoxifen on Lipid Levels: Revised and Updated Results

Suchergebnisse filtern